FDA Says UK Company Exporting to U.S. Without Registration, Drug Listing

Drug Industry Daily
An FDA review into shipments of drugs from a UK company to the U.S. revealed that Wallace Cameron International has not fulfilled its establishment registration and drug listing obligations but continued to manufacture, prepare, propagate and process drugs that were exported to the U.S.

To View This Article:


Subscribe To Drug Industry Daily